Literature DB >> 11377802

Mitochondrial contributions to cancer cell physiology: potential for drug development.

T J Preston1, A Abadi, L Wilson, G Singh.   

Abstract

Mitochondria make an integral contribution to the regulation of several aspects of cell biology such as energy production, molecular metabolism, redox status, calcium signalling and programmed cell death. In accordance with an endosymbiotic origin, mitochondria rely upon the nucleus for synthesis and function. In addition, these organelles can respond to intra- and extracellular cues independently, and there exists a highly coordinated "cross talk" between mitochondrial and nuclear signals that can greatly influence cell behaviour. This review focuses upon the putative roles of altered mitochondrial physiology in the process of cellular transformation. Discussed are: mitochondria as targets of drug-induced cytotoxicity or cancer promotion, as regulators of apoptosis, as sources of cell signalling through reactive oxygen species, and mitochondrial control of specific nuclear responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377802     DOI: 10.1016/s0169-409x(01)00127-2

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  15 in total

Review 1.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

3.  Mahanine, a carbazole alkaloid from Micromelum minutum, inhibits cell growth and induces apoptosis in U937 cells through a mitochondrial dependent pathway.

Authors:  Molay Kumar Roy; Vipaporn Na Thalang; Gassinee Trakoontivakorn; Kazuhiko Nakahara
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

4.  Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines.

Authors:  Corinne E Griguer; Claudia R Oliva; G Yancey Gillespie
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

5.  Antitumor activity of a sulfated polysaccharide from Enteromorpha intestinalis targeted against hepatoma through mitochondrial pathway.

Authors:  Xuxia Wang; Ying Chen; Jingjie Wang; Zhenxiong Liu; Shuguang Zhao
Journal:  Tumour Biol       Date:  2013-10-02

Review 6.  Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis.

Authors:  Jianxin Lu; Lokendra Kumar Sharma; Yidong Bai
Journal:  Cell Res       Date:  2009-07       Impact factor: 25.617

7.  Mitochondrial transcription factor A and its downstream targets are up-regulated in a rat hepatoma.

Authors:  Xiaocheng Dong; Kalpana Ghoshal; Sarmila Majumder; Satya P Yadav; Samson T Jacob
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

Review 8.  Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer.

Authors:  Kevin J Cullen; Zejia Yang; Lisa Schumaker; Zhongmin Guo
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

9.  Endoplasmic reticulum stress-induced JNK activation is a critical event leading to mitochondria-mediated cell death caused by β-lapachone treatment.

Authors:  Hyemi Lee; Moon-Taek Park; Bo-Hwa Choi; Eun-Taex Oh; Min-Jeong Song; Jeonghun Lee; Chulhee Kim; Byung Uk Lim; Heon Joo Park
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.752

10.  The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cells.

Authors:  Hyoun-Ji Kim; Kwang-Mo Yang; Yoo-Soo Park; Yoo-Jin Choi; Ji-Hyeon Yun; Cheol-Hun Son; Hong-Suk Suh; Min-Ho Jeong; Wol-Soon Jo
Journal:  Int J Oncol       Date:  2012-08-31       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.